HTG Molecular Diagnostics, Inc. (65H.F)

0.0000 -7.6860 (-100.00%) As of 09:36AM CEST. Market open.

HTG Molecular Diagnostics, Inc.

3430 East Global Loop
Tucson, AZ 85706
United States
877 289 2615
https://www.htgmolecular.com

Sector(s): 
Industry: 
Full-time employees: 53

Key executives

Name	Title	Pay	Exercised	Year born
Mr. John L. Lubniewski	President, CEO & Director	762.41k	N/A	1964
Mr. Shaun D. McMeans	Senior VP, CFO, Secretary & Treasurer	495.74k	N/A	1962
Ms. Laura Lee Godlewski	Senior Vice President of Finance & Administration	N/A	N/A	1980
Dr. Debra A. Gordon	Senior VP & Chief Legal Counsel	203.76k	N/A	1960
Dr. Patrick C. Roche	Senior Vice President of Research & Development	239.14k	N/A	1953
Dr. Stephen A. Barat Ph.D.	Senior Vice President of Therapeutics	N/A	N/A	1970
Dr. Christina M. Carruthers Ph.D.	Vice President of Target Strategy & Early Development	N/A	N/A	N/A
Debrah Thompson	Vice President of Scientific Innovation	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in .

Description

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Corporate governance

HTG Molecular Diagnostics, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.